HJLI - ハンコック・ジャフィ・ラボラトリ―ズ （Hancock Jaffe Laboratories Inc.） ハンコック・ジャフィ・ラボラトリ―ズHJLIのチャート
HJLIの企業情報
| symbol | HJLI |
|---|---|
| 会社名 | Hancock Jaffe Laboratories Inc （ハンコック・ジャフィ・ラボラトリ―ズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 Hancock Jaffe Laboratories Inc. is a development stage medical device company. The Company is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease peripheral arterial and venous disease and end stage renal disease (ESRD). The Company is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV) is a bioprosthetic pig heart valve designed to function like a native heart valve and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic pig venous valve for patients with lower limb chronic venous insufficiency (CVI) which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system. ハンコック・ジャフィ・ラボラトリ―ズは米国の医療機器会社。冠状動脈、血管、末梢動脈など心臓に関する疾患を治療するために、生体組織溶液の開発・商業化に従事する。同社は移植可能な心血管バイオプロテ―ゼ・デバイスを開発・製造し、主な製品に「VenoValve」や「CreoGraft」などを含む。本社所在地はカリフォルニア州ア―バイン。 Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery. |
| 本社所在地 | 70 Doppler Ivine CA 92918 USA |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | +1 949-261-2900 |
| 設立年月日 | － |
| 市場名 | NASDAQ Small Cap |
| ipoyear | 2018年 |
| 従業員数 | － |
| url | www.hancockjaffe.com |
| nasdaq_url | https://www.nasdaq.com/symbol/hjli |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -8.17638 |
| 終値（lastsale） | 2.8654 |
| 時価総額（marketcap） | 33574771.4778 |
| 時価総額 | 時価総額（百万ドル） 28.47306 |
| 売上高 | 売上高（百万ドル） 0.31743 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 22.53064 |
| 当期純利益 | 当期純利益（百万ドル） -18.72681 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Hancock Jaffe Laboratories Inc revenues decreased 48% to $114K. Net loss applicable to common stockholders increased from $2.6M to $13.1M. Revenues reflect Product Sales decrease from $152K to $0K Royalty Income decrease of 10% to $60K. Higher net loss reflects Amortization of debt discount increase from $24K to $6.6M (expense) Selling/General/Admin. Expense increase of 95% to $4.2M (expense). |
HJLIのテクニカル分析
HJLIのニュース
Hancock Jaffe To Rebrand As enVVeno Medical 2021/09/22 11:09:30 Benzinga
Full story available on Benzinga.com
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs 2021/09/21 20:08:00 FinanzNachrichten
- Hancock Jaffe changing name to enVVeno Medical Corporation and ticker symbol to NASDAQ: NVNO, effective October 1, 2021 -- Development strategy to focus on venous disease and advancement of the V
Breathtaking stocks: MannKind Corporation (NASDAQ:MNKD -1.54%), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI 3.14%) 2021/09/17 23:51:31 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Breathtaking stocks: MannKind Corporation (NASDAQ:MNKD -1.54%), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI 3.14%) appeared first on Stocks Equity .
Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics 2021/09/08 23:43:33 Seeking Alpha
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference 2021/07/08 13:08:00 FinanzNachrichten
Live webcast on Tuesday, July 13th at 1:00 PM ETIRVINE, CA / ACCESSWIRE / July 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical de
Up to Date Trending Stock: Delta Air Lines, Inc. (NYSE:DAL), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) 2021/07/08 02:06:11 Stock Equity
Delta Air Lines, Inc. (NYSE:DAL) with the stream of -1.06% also noticed, India Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) encountered a rapid change of -3.85% in the last hour of Wednesdays The post Up to Date Trending Stock: Delta Air Lines, Inc. (NYSE:DAL), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) appeared first on Stocks Equity .
Heres What to Focus on: APA Corporation (NASDAQ:APA), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) 2021/07/02 00:01:47 Stock Equity
APA Corporation (NASDAQ:APA) with the stream of 2.52% also noticed, India Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) encountered a rapid change of -4.51% in the last hour of Thursdays trading session. The post Heres What to Focus on: APA Corporation (NASDAQ:APA), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) appeared first on Stocks Equity .
Eye-catching Hot Stock: Ocugen, Inc. (NASDAQ:OCGN), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) 2021/06/25 23:38:11 Stock Equity
Ocugen, Inc. (NASDAQ:OCGN) with the stream of -2.09% also noticed, India Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) encountered a rapid change of 2.61% in the last hour of Fridays trading session. The post Eye-catching Hot Stock: Ocugen, Inc. (NASDAQ:OCGN), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) appeared first on Stocks Equity .
Eye-catching Hot Stock: Ocugen, Inc. (NASDAQ:OCGN), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) 2021/06/25 23:38:11 Stock Equity
Ocugen, Inc. (NASDAQ:OCGN) with the stream of -2.09% also noticed, India Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) encountered a rapid change of 2.61% in the last hour of Fridays trading session. The post Eye-catching Hot Stock: Ocugen, Inc. (NASDAQ:OCGN), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) appeared first on Stocks Equity .
Hot Mover to Watch: Cisco Systems, Inc. (NASDAQ:CSCO), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) 2021/06/17 22:15:46 Stock Equity
Cisco Systems, Inc. (CSCO) with the stream of -0.48% also noticed, India Hancock Jaffe Laboratories, Inc. (HJLI) encountered a rapid change of -3.36% in the last hour of Thursdays trading The post Hot Mover to Watch: Cisco Systems, Inc. (NASDAQ:CSCO), Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) appeared first on Stocks Equity .
Hancock Jaffe Laboratories Inc. Shares Close the Week 22.8% Lower - Weekly Wrap 2021/02/12 22:30:00 Kwhen Finance
Hancock Jaffe Laboratories Inc. shares closed this week 22.8% lower than it did at the end of last week. The stock is currently down 12.9% year-to-date, down 57.6% over the past 12 months, and down 94.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 1.3%. Trading Activity Shares traded as high as $9.86 and as low as $6.96 this week.Shares closed 6e+1% below its 52-week high and 4e+1% above its 52-week low.Trading volume this week was 10.0% higher than the 10-day average and 175.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -158.7% The company's stock price performance over the past 12 months lags the peer average by -209.4%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Hancock Jaffe Laboratories Inc. Shares Close the Week 56.4% Higher - Weekly Wrap 2020/12/11 22:30:00 Kwhen Finance
Hancock Jaffe Laboratories Inc. shares closed the week 56.4% higher than it did at the end of last week. The stock is currently down 16.1% year-to-date, up 0.8% over the past 12 months, and down 91.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $17.68 and as low as $7.40 this week. Shares closed 4e+1% below its 52-week high and 7e+1% above its 52-week low. Trading volume this week was 98.0% lower than the 10-day average and 94.8% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates a downward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 33.5% higher than its 5-day moving average, 38.2% higher than its 20-day moving average, and 292.8% higher than its 90-day moving average.
Market Comparative Performance The company's share price beats the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio beats its average peer by -100.0% The company's performance over the last 1 year beats its average peer by -114.0%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.